Related by context. All words. (Click for frequent words.) 62 colorectal adenoma 62 torsade de pointes 62 erosive esophagitis 61 Acting Injection 61 gastric acid secretion 60 GI motility 60 dysmenorrhoea 59 serum phosphate 59 relapsed MM 58 opioid analgesia 58 pamidronate 58 salmeterol fluticasone 58 flutamide 58 CIMZIA R 58 NU# direct 58 corticosteroid therapy 58 acting injectable formulation 58 leucopenia 58 EMBEDA ™ 58 nadolol 58 acromegalic patients 57 QT intervals 57 hepatic enzymes 57 overt nephropathy 57 dalteparin 57 DAPT 57 recurrent genital herpes 57 serum calcium levels 57 LHRH agonists 57 bipolar mania trials 57 ACIPHEX 57 MIRAPEX 57 inhaled budesonide 57 QTc interval 56 β blockers 56 R tizanidine hydrochloride 56 menstrual migraine 56 inotropes 56 cytoreduction 56 hyperalgesia 56 alanine aminotransferase ALT 56 intravitreal injections 56 COPD exacerbation 56 hour bronchodilation 56 severe neutropenia 56 corticosteroid dose 56 dosing frequency 56 recurrent VTE 56 FOSRENOL ® 56 AGILECT R 56 peripheral neuropathies 56 uric acid lowering 56 Chronic pancreatitis 56 acting inhaled anticholinergic 56 inhaled iloprost 56 dose corticosteroids 56 androgen suppression 56 unresectable HCC 56 intravenous cyclophosphamide 55 CYT# QbG# 55 HAART regimen 55 Insulin PH# 55 acting insulins 55 activated partial thromboplastin 55 tolterodine 55 Venous thromboembolism 55 adjunctive placebo 55 erectile dysfunction impotence 55 endometrial carcinoma 55 ropinirole 55 hemorrhagic complications 55 guanfacine 55 headache stiffness nausea 55 QT syndrome 55 Major Depressive Disorder MDD 55 subcutaneous infusion 55 severe exacerbations 55 plasminogen activators 55 subcutaneous SC 55 bronchoconstriction 55 desvenlafaxine succinate 55 systemic corticosteroids 55 NATRECOR ® 54 gastroduodenal 54 CIMZIA ™ 54 atazanavir ritonavir 54 L dopa 54 aromatase inhibitor therapy 54 paroxysmal AF 54 LATUDA 54 Paliperidone 54 anticoagulant medications 54 pegylated IFN 54 repolarization 54 QT QTc 54 acting beta agonists 54 term potentiation LTP 54 chain polyunsaturated fatty 54 recurrent venous thromboembolism 54 CIMZIA TM 54 nasal symptoms 54 macrovascular events 54 clonidine hydrochloride 54 hypopigmentation 54 uterine fibroid induced 54 partial thromboplastin 54 aminotransferase elevations greater 54 pretransplant 54 thrombin inhibiting aptamer 54 rFSH 54 posttransplant 53 levodopa therapy 53 acting beta agonist 53 racemic albuterol 53 #mg/day [002] 53 dose cyclophosphamide 53 intermittent dosing 53 PRADAXA #mg 53 H2RAs 53 acting bronchodilators 53 thromboses 53 fluticasone salmeterol 53 synthetically derived oligonucleotides 53 postoperative AF 53 divalproex sodium 53 nausea somnolence 53 oral analgesics 53 neurologic progression 53 Lucentis ranibizumab Genentech 53 HBeAg seroconversion 53 methotrexate therapy 53 frequent awakenings 53 non progressors 53 painful erections 53 QT interval 53 amenorrhea 52 Calorie restriction 52 ancrod 52 Mycophenolate mofetil 52 nasal aerosol 52 androgen deprivation 52 STRIDE PD 52 corrected QT interval 52 urate lowering therapy 52 paranasal sinuses 52 APTIVUS r 52 interferon beta therapy 52 symptomatic intracranial hemorrhage 52 glycated hemoglobin levels 52 menstrual bleeding 52 Hormonal therapy 52 neurocognitive function 52 Nocturia 52 GnRH agonist 52 AGHD 52 intravenous IV infusion 52 dose titration 52 adjuvant tamoxifen 52 transaminase levels 52 dose regimens 52 Tasigna prolongs 52 INVEGA ® 52 intravenous vancomycin 52 detectable HCV RNA 52 thromboprophylaxis 52 GnRH antagonist 52 adenoma recurrence 52 androgen suppression therapy 52 intraventricular 52 acting insulin analogues 52 urinary N telopeptide 52 urethral strictures 52 prolonged QT interval 52 p = NS 52 antiepileptic medications 52 nonvertebral fractures 52 uM 52 mesalamine granules 52 dosing interval 51 oral methylnaltrexone 51 â ‰ ¥ 51 maximal doses 51 weekly subcutaneous injections 51 USL# 51 dosage regimens 51 histrelin 51 mg subcutaneously 51 timepoints 51 androgen ablation 51 coronary stenosis 51 nadroparin 51 bezafibrate 51 serum lipid levels 51 gout flares 51 GLP1 agonist 51 NATRECOR R 51 carotid IMT 51 potassium supplementation 51 dosing intervals 51 resolves spontaneously 51 neurologic dysfunction 51 transaminases 51 loop diuretics 51 #mg doses [002] 51 insulin detemir 51 neurocognitive outcomes 51 IX Fc fusion 51 μg liter 51 lactate dehydrogenase 51 cough wheezing 51 alteplase 51 #mg/m# [001] 51 follicular phase 51 dosing cohort 51 serum bicarbonate 51 serum sodium levels 51 Fc fusion protein rFVIIIFc 51 μg mL 51 intravenous dosing 51 concentration Cmax 51 x ULN 51 APRISO 51 selegiline 51 dual antiplatelet therapy 51 Calcium intake 51 oral anticoagulation 51 bronchodilators 51 lesional 51 rFIXFc 51 acetazolamide 51 serum homocysteine 51 nanomolar 51 TPO mimetic 51 citalopram hydrobromide 51 thrombocytopenic patients 50 fibrinolysis 50 dosing regimens 50 rituximab Rituxan ® 50 continuous intravenous infusion 50 bronchodilation 50 subcutaneous methylnaltrexone 50 insomnia somnolence 50 β blocker 50 ziprasidone 50 Perceiva 50 symptomatic VTE 50 cardiac morbidity 50 crossclamp 50 oral corticosteroid 50 dosage regimen 50 oral prednisolone 50 low dose cytarabine 50 nocturnal hypoglycaemia 50 protein rFIXFc 50 #mg/m# [002] 50 seminomas 50 urinary excretion 50 Febrile neutropenia 50 luteal 50 mIU ml 50 serum PTH 50 virologic suppression 50 mg/m2 dose 50 registrational clinical 50 care hospitals LTACHs 50 pulmonary dysfunction 50 immuno suppression 50 tipranavir r 50 lacosamide 50 IFN alpha XL 50 Chronic bronchitis 50 ug kg 50 dose prednisone 50 PASI scores 50 baseline LDH 50 K ras mutations 50 pCR 50 rebleeding 49 neurologic complications 49 Cohort Study MACS 49 pulmonary exacerbations 49 DAS# CRP 49 serum concentrations 49 Repellents containing 49 percutaneous interventions 49 RLAI 49 dipyridamole 49 mg/m2/day 49 femoral shaft fracture 49 bariatric clinics 49 HER2 expression 49 maximally tolerated 49 CCyR 49 IOP lowering 49 5 HT2C receptor 49 dipyridamole plus 49 disease progression TTP 49 Gabapentin GR 49 PSVT 49 CorVue ™ 49 epigastric pain 49 pharmacodynamics PD 49 mg QD 49 QTc intervals 49 calcium antagonist 49 myocardial ischaemia 49 antiviral efficacy 49 Zemplar Capsules 49 tapentadol ER 49 airflow obstruction 49 sequelae 49 genotypic resistance 49 elevated IOP 49 premenstrual dysphoric disorder 49 neutrophil counts 49 virologic response 49 atrial tachyarrhythmias 49 prolactin levels 49 pulsed dye laser 49 FFNS 49 gastric acidity 49 dose cohort 49 NB UVB 49 topical NSAIDs 49 acute asthma exacerbations 49 rhIGF 1 49 CDI recurrence 49 ipsilateral stroke 49 cerebrovascular accidents 49 Brugada syndrome 49 antiretroviral naive 49 virologic failure 49 triacylglycerol concentrations 49 incidence ≥ 49 sore throats nausea 49 Perforomist TM formoterol fumarate 49 mg q8h 49 spontaneous bowel movements 48 incontinence episodes 48 leukotriene modifiers 48 rapid virologic response 48 Diamyd ® 48 acting atypical antipsychotic 48 conjugated equine estrogen 48 antiangiogenic agents 48 ALT elevation 48 AUC0 48 Active Ulcerative Colitis 48 wavelength ultraviolet 48 LUTS 48 Scale EDSS score 48 asthma exacerbation 48 bowel resection 48 QTcF 48 telomerase activity 48 prolonged QT intervals 48 combinability 48 nausea vomiting cramps 48 echocardiographic parameters 48 IGFBP 48 ventricular tachyarrhythmia 48 postoperative mortality 48 serum aminotransferase levels 48 Index CDAI 48 symptom flare ups 48 solifenacin 48 virologic breakthrough 48 seropositivity 48 Crohn Disease Activity 48 mg simvastatin 48 EDSS scores 48 claudication 48 anovulatory 48 luteal phase 48 QAB# indacaterol 48 Gentle Path compound 48 ‰ ¥ 48 hypoglycaemic episodes 48 postmenopausal estrogen 48 ventricular repolarization 48 mg kg dose 48 cortisol secretion 48 serum magnesium 48 release fampridine tablets 48 nausea diarrhea vomiting 48 Skin sterol 48 ZOMIG Nasal Spray 48 biochemical marker 48 Raptiva r 48 μmol L 48 #mg q8h 48 peak plasma concentrations 48 blood glucose concentrations 48 pharmacodynamic parameters 48 pharmacokinetic characteristics 48 pegylated interferon alfa 2b 48 antiangiogenic therapy 48 periprocedural 48 nonoperative treatment 48 fructosamine 48 serum potassium levels 48 SHBG levels 48 serum urate 48 clopidogrel therapy 48 surgical debulking 48 serum lipid 48 dose proportional pharmacokinetics 48 nonmetastatic prostate cancer 47 NNT = 47 myocardial contractility 47 analgesic efficacy 47 telaprevir dosing 47 platelet reactivity 47 ng dL 47 #mg QD [001] 47 rapid virological response 47 Macular edema 47 glycosylated hemoglobin levels 47 vaginal moisturizer 47 anagen 47 ENTEREG 47 retinal thickness 47 Scale EDSS 47 Treatment emergent adverse 47 amyloidogenic 47 Endothelial function 47 antidiabetic medications 47 serum ALT 47 dual antiplatelet 47 carboplatin AUC 6 47 androgen blockade 47 preoperative radiotherapy 47 inflammatory biomarkers 47 poststroke 47 mianserin 47 postoperative complications 47 esophageal acid 47 PegIFN RBV 47 symptomatic atrial fibrillation 47 inhaled tobramycin 47 Finerman Firm Is 47 posttreatment 47 intramuscularly 47 radiographic progression 47 oxyhemoglobin 47 akinesia 47 Titan proprietary ProNeura 47 gastric pH 47 interquartile range 47 urate lowering 47 Kaplan Meier estimate 47 CD# upregulation 47 tachycardias 47 cerebral ischemic 47 hypofractionated 47 randomized multicenter Phase III 47 aplindore 47 cerebrovascular events 47 telomere lengths 47 tiotropium 47 neurodevelopmental outcome 47 term Shahar unlinked 47 dyskinesias 47 paclitaxel eluting stents 47 rotigotine 47 plasma glucose concentration 47 anti miRs 47 term potentiation 47 post prandial glucose 47 apnea hypopnea 47 Hormonal imbalances 47 apneic episodes 47 oral prednisone 47 pharmacokinetic parameters 47 HBV DNA levels 47 CR nPR 47 headache dizziness fatigue 47 lactate dehydrogenase LDH 47 ABC/3TC 47 thrombus formation 47 Settle Announce Allot 47 THCA represents 47 hypoglycemia unawareness 47 preintervention 47 moderately emetogenic 47 foveal thickness 47 placebo controlled trials 47 ug dose 47 tezampanel NGX# 47 postoperative chemotherapy 47 AUC0 #hr 47 cART 47 SCr 46 reactogenicity 46 systolic dysfunction 46 TDF FTC 46 CK MB 46 QRS interval 46 aminotransferase levels 46 hypofractionated radiation 46 CAG repeats 46 osmolality 46 neurologic deficits 46 Postoperatively 46 mm ³ 46 electrical cardioversion 46 Vojo Vukovic MD Ph.D. 46 CDAI 46 interfering RNAs siRNAs 46 eszopiclone 46 intradermal injections 46 FOLPI 46 inhaled glucocorticoids 46 oral corticosteroids 46 acute febrile 46 postintervention 46 eprodisate Fibrillex TM 46 autoregulation 46 anagen phase 46 SpO 2 46 clock opioid 46 postoperative 46 DLTs 46 premenstrual symptoms 46 oral FTY# 46 hypopneas 46 O PPDS 46 L PPDS 46 physiologic parameters 46 QTc 46 hypoglycemic episodes 46 adenoid tissue 46 headache vomiting nausea 46 Preterm infants 46 nicotinamide adenine dinucleotide phosphate 46 Hb levels 46 healthspan 46 L DOPA 46 URTI 46 Inc. NPWZ 46 PSADT 46 transdermal nicotine 46 PASI score 46 glycemia 46 hormonal fluctuation 46 indiplon capsules 46 fraction LVEF 46 flashbacks irritability 46 postoperative bleeding 46 Sleep disordered breathing 46 CK # plasma concentrations 46 diabetes NIDDM 46 Score DAS 46 hemoglobin A1c levels 46 syncopal 46 nausea diarrhea fatigue 46 quetiapine 46 endoscopic remission 46 fatty infiltration 46 evaluable subjects 45 dose Iluvien 45 Chronic pelvic 45 pathologic fractures 45 ovulatory 45 titration phase 45 alicaforsen enema 45 osteoporosis brittle bones 45 nulliparous women 45 pharmacodynamic effects 45 placebo dummy pill 45 laxation 45 placebo controlled 45 renal cysts 45 Sexual dysfunction 45 p = #.# [003] 45 headache somnolence 45 LFTs 45 unrefreshing sleep 45 ICD shocks 45 neurologic sequelae 45 F FDG PET 45 TURBT 45 CMV reactivation 45 gout flare 45 timepoint 45 Vertebral fractures 45 mg orally 45 liver biopsies 45 atheromatous 45 death reinfarction 45 chemical picaridin 45 treatment naive genotype 45 Fasting plasma glucose 45 affective psychosis 45 venlafaxine ER 45 concomitant medications 45 arteriolar 45 UV irradiation 45 virological response 45 tumor progression TTP 45 repeat paracentesis 45 plasma glucose levels 45 creatine kinase MB 45 metabolic parameters 45 aortic crossclamp 45 Dose escalation 45 polytherapy 45 progression TTP 45 transgene expression 45 intensity aerobic exercise 45 lymphocyte count 45 HbA 1c levels 45 extubation 45 asystole 45 Adverse effects 45 ventricular tachyarrhythmias 45 plasma cortisol 44 EEG abnormalities 44 adenotonsillectomy 44 hypopnea 44 Evaluable 44 prodromal phase 44 Asentar 44 optimal dosing 44 ispinesib administered 44 demonstrated clinically meaningful 44 nasal airflow 44 pointers beagles 44 anticoagulant therapy 44 paresthesia 44 oligohydramnios 44 pharmacokinetics PK 44 erections lasting 44 MVax 44 hemodynamically stable 44 Metastatic colorectal cancer 44 dose proportionality 44 euthymic 44 compare levitra viagra 44 durations 44 related hematological toxicity 44 OGTT 44 Aerobic exercise 44 DAS# remission 44 QALE 44 mg kg IV 44 μg doses 44 Galil CPI 44 nausea vomiting diarrhea abdominal 44 expiratory 44 #.#-#.# [011] 44 poststroke depression 44 Cluster headaches 44 locomotor activity 44 RLS symptoms 44 dizziness nausea confusion 44 respirable droplets delivered 44 thorough QT 44 untreated psychosis 44 IELT 44 Left Ventricular Ejection Fraction 44 comorbid disorders 44 recurrent ischemic 44 dose regimen 44 Lifespans 44 baroreceptor 44 ocular dryness 44 Cmax 44 premixed insulin 44 vigorous aerobic exercise 44 intravenous CK # 44 comorbid psychiatric 44 prospectively stratified 44 hyperintense lesions 44 symptom exacerbation 44 Index CDAI score 44 product Fenoglide TM 44 EDSS score 44 prothrombin 44 afterload 44 postprandial blood glucose 44 PFPS 44 antibody titer 44 Lupuzor ™ 44 pharmacological treatments 44 using slickwater 44 tooth discoloration 44 carbohydrate oxidation 44 ordinarily harmless intestinal 44 BPH symptoms 44 Replens Long 44 redness erythema 44 chronicity 44 airflow limitation 44 Cardiorespiratory fitness 44 events TEAEs 44 serum HCV RNA 44 facial palsy 44 #mg/dl 44 gait disturbances 44 equianalgesic dose 44 5 HTTLPR 43 Vectical TM Ointment 43 cortical excitability 43 creatine supplementation 43 sub maximal 43 enuresis 43 Premature ejaculation 43 MARKET DATA - 43 endometrial thickness 43 prolonged immobilization 43 CASH FLOW INVESTMENT ACTIVITIES 43 postprocedure 43 premenopause 43 bolus doses 43 Intraocular pressure 43 rates EURIBORSWD = 43 systolic ejection 43 inhaled anticholinergics 43 dosed intravenously 43 liabilities Current maturities 43 A1c levels 43 fasting glucose levels 43 salivary cortisol 43 label titration 43 Free Survival PFS 43 nausea dizziness vomiting 43 cervical secretions 43 postdose 43 tertiles 43 tumor histology 43 daytime alertness 43 HAM D# 43 clinically meaningful improvements 43 per deciliter mg 43 atherothrombotic 43 surgically induced 43 term IDR F2 43 Cognitive behavioral 43 PSA nadir 43 EndoTAGTM 1 43 hypoxic respiratory failure 43 Score IPSS 43 annualized relapse 43 postop 43 Secondary efficacy endpoints 43 mutually monogamous 43 ABILIFY Injection 43 peri procedural 43 ADAS Cog 43 postoperative hemorrhage 43 ischemic cerebrovascular 43 Symptom severity 43 hypoglycemic events 43 IU ml 43 fever nausea dizziness 43 Somnolence 43 - Announce Allot 43 status epilepticus 43 intravenous REOLYSIN 43 interquartile range IQR 43 diarrhea abdominal cramps 43 postvaccination 43 CI -#.# 43 concomitant AEDs 43 urology Ob Gyn 43 PRNewswire BullMarket.com http:/www.bullmarket.coTafataona Mahoso 42 ml kg 42 virological failure 42 XR NTX 42 HbA1C levels 42 imminant reversal 42 IDR F1 42 Main Outcome Measure 42 prolonged erection priapism 42 histologies 42 Climara Pro 42 mg Pycnogenol 42 Liabilities Current maturities 42 percutaneous intervention 42 mg/m2 cohort 42 Current liabilities Current maturities 42 divalproex 42 mild renal impairment 42 transient insomnia 42 psychodynamic psychotherapy 42 PLMs 42 Notice Regarding Forward Looking 42 systolic function 42 HbA1c levels 42 plasma viremia 42 Secondary endpoints include 42 arterial oxygen saturation 42 QRS duration 42 thicker eyelashes 42 postoperatively 42 oral olanzapine 42 Visual acuity 42 secondary efficacy endpoint 42 urinary albumin excretion 42 Secondary endpoints 42 randomized #:#:# 42 emesis 42 TT genotype 42 THE DISCLOSURE Interests 42 CDAI score 42 mmHg systolic 42 angiographic restenosis 42 BTCP 42 wrinkle correction 42 postprandial glucose 42 androgen ablation therapy 42 System IPSS 42 moisturisation 42 Score DAS# 42 mg kg hr 42 swelling stiffness 42 manic hypomanic 42 oncologic outcomes 42 Accounts Receivable Billed 42 plasma HCV RNA 42 Secondary endpoints included 42 INRs 42 glucose tolerance 42 methotrexate monotherapy 42 DES implantation 42 postinjury 42 Inventory BPI 42 Viral load 41 axial length 41 label dose titration 41 plasma concentration Cmax 41 expiratory flow 41 brachial artery flow 41 mL kg 41 IWM SPY 41 pretreatment baseline 41 interconversion 41 abdominal circumference 41 subcutaneous PRO 41 Haskell Karp 41 spirometric 41 Settlement Date shall 41 constipation akathisia postural hypotension 41 dose inhaled corticosteroids 41 wavelength lasers 41 telomere length 41 attain statistical significance 41 care NCCN promotes 41 Chronic insomnia 41 nighttime awakenings 41 #:# mediaQueryString http:/static.washingtonpostZanatta 41 fatigue dizziness nausea 41 ischemic lesions 41 cosmetically acceptable 41 morbidity mortality 41 obstructive apnea 41 Reactive oxygen species 41 sUA levels 41 apnea hypopnea index 41 estimated glomerular filtration 41 Hazard Ratio = 41 flow mediated dilation 41 ambulation 41 Visual Analogue Scale VAS 41 glucose concentrations 41 Rotavirus infection 41 hemoglobin A1c HbA1c 41 ≥ Grade 41 QRS width 41 UBS E Tracs 41 anogenital distance 41 peri menopause 41 NPWZ 41 orange reticulated python 41 central corneal thickness 41 LIBOR indexed 41 nonobstructive CAD 41 takes Celeb birthdays 41 Qmax 41 dyspnea shortness 41 #:# randomization 41 maturity WAM 41 plasma glucose 41 facial filler 41 carboplatin AUC 41 ULN 41 ragweed allergic 41 AMOR IPAT 41 CHD CVD 41 Ton U#O# 41 durable remissions 41 mcg kg 41 nevirapine regimen 41 desaturation 41 NIH CPSI 41 borrowings subordinated debentures 40 prespecified 40 Psychosocial interventions 40 daytime somnolence 40 dose escalation phase 40 Tmax 40 RNA copies mL 40 diapause 40 HIV seroconversion 40 physiologic responses 40 λ 40 running thriller Deathtrap 40 vivo coagulation 40 symptom onset 40 MSLT 40 Triglyceride levels 40 urinary sodium excretion 40 Osprey tiltrotor vertical 40 submaximal 40 thicker fuller 40 impaired endothelial 40 Epley maneuver 40 quadrillionths 40 oxygen desaturation 40 fever abdominal cramps 40 anti miRs targeting 40 Platinum ETN 40 herb echinacea 40 Form Prospectus dated 40 LIABILITIES Current 40 symptom severity 40 redden swell 40 daytime siesta 40 RLS sufferers 40 Peg riba 40 convulsions tremors 40 oocytes retrieved 40 duty constable Salesi 40 Ceplene/IL-2 40 Congressman Solarz 40 Ph.D. RehabCare 40 Thorough QT 40 traction alopecia 40 chest radiography 40 Cortisone injections 40 pulse amplitude 40 ejaculatory function 39 continuously abstinent 39 sunscreen ingredients avobenzone 39 cecal intubation 39 preventing recurrences 39 birth asphyxia 39 dyspnea 39 hemophilia therapies 39 Zolpidem Tartrate Tablets 39 #:# mediaQueryString http:/static.washingtonposFilmworkers 39 fatal arrhythmic 39 nasal symptom 39 mental fogginess 39 photoaged skin 39 El Niño Southern Oscillation 39 inspiratory 39 arousals 39 sigmoid 39 wavelength infrared 39 nonfasting 39 4q 39 sleep apnea narcolepsy 39 ASSETS Cash cash equivalents 39 Atlantic Multidecadal Oscillation AMO 39 baseline CD4 39 irregular menstrual periods 39 acne breakouts 39 severe keratitis 39 apneas 39 photoperiodic 39 CLI summarizes information 39 Persistent Sleep 39 Family Feud syndicated 39 MMSE scores 39 hemoglobin concentrations 39 maximal aerobic 39 plasma glucose concentrations 39 ARTISTRY ® 39 PM#.# exposure 39 stopping PEGINTRON 39 intravenous tPA 39 South Carolinian Strom 39 Dated Treasurys 39 M2 M1 39 DAS# scores 39 collected saliva samples 39 maximal aerobic capacity 39 hospitalization Finelli 39 prodromal 39 Marketing SIMULIA Dassault 39 winded anecdotes 38 Kaplan Meier estimates 38 MS CDMS 38 hypomanic episode 38 intravaginal ejaculatory latency 38 HAQ DI 38 IBDQ